DWT
STIM icon

Dorsey & Whitney Trust’s Neuronetics STIM Stock Holding History

Dorsey & Whitney Trust’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-95,880
Closed -$173K – 686
2024
Q2 		$173K Buy
95,880
+47,228
+97% +$136K 0.01% 604
2024
Q1 		$232K Buy
48,652
+16,855
+53% +$59.2K 0.02% 556
2023
Q4 		$92.2K Hold
31,797
– – 0.01% 601
2023
Q3 		$42.9K Hold
31,797
– – ﹤0.01% 578
2023
Q2 		$68.4K Hold
31,797
– – 0.01% 577
2023
Q1 		$92.5K Hold
31,797
– – 0.01% 558
2022
Q4 		$218K Hold
31,797
– – 0.02% 505
2022
Q3 		$101K Hold
31,797
– – 0.01% 527
2022
Q2 		$102K Hold
31,797
– – 0.01% 527
2022
Q1 		$96K Buy
31,797
+2,796
+10% +$9.45K 0.01% 558
2021
Q4 		$129K Hold
29,001
– – 0.01% 550
2021
Q3 		$190K Buy
29,001
+16,231
+127% +$156K 0.02% 519
2021
Q2 		$205K Hold
12,770
– – 0.02% 503
2021
Q1 		$158K Buy
+12,770
New +$196K 0.02% 507

Other funds holding STIM

KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dorsey & Whitney Trust's STIM Position: Q3 2024 in Review

Dorsey & Whitney Trust sold out of Neuronetics (STIM) in Q3 2024, closing a stake of 95,880 shares — an estimated $173K sold.

Dorsey & Whitney Trust first reported a position in STIM in Q1 2021 and held it in 14 quarters. The position peaked at $232K in Q1 2024. 48 funds tracked by Wall St. Rank hold STIM as of Q3 2024.

  • Dorsey & Whitney Trust reported no remaining Neuronetics position as of Q3 2024 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 95,880 Neuronetics shares in Q3 2024, an estimated $173K.
  • Dorsey & Whitney Trust first reported a position in Neuronetics in Q1 2021 and held it in 14 quarters.
  • Dorsey & Whitney Trust's Neuronetics position peaked at $232K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Neuronetics as of Q3 2024.

Based on Dorsey & Whitney Trust's 13F filing for Q3 2024, filed 12 Nov 2024.